术前加速部分乳腺照射早期反应的病理、MRI与FDG PET/CT评估
该研究分析66例低危乳腺癌患者(≥60岁,cT1-2pN0),在接受术前加速部分乳腺照射(10×4 Gy或5×6 Gy)后6周行局部扩大切除。病理评估显示15例(23%)接近完全缓解、28例(42%)部分缓解、23例(35%)无缓解。MRI(RECIST)预测完全缓解的PPV为87.5%、NPV为85%;PET/CT的PPV为25%、NPV为92%,MRI为最准确方法。
要点
- 66例低危乳腺癌患者中23%达(近)病理完全缓解,42%部分缓解,35%无缓解。
- MRI(RECIST)预测病理完全缓解的PPV为87.5%,NPV为85%。
- PET/CT预测病理完全缓解的PPV仅25%,NPV为92%。
核心结论
- 在低危乳腺癌术前加速部分乳腺照射后,MRI(RECIST)是预测缓解与残留病灶最准确的方法。
研究设计与样本
- 分析PAPBI试验中66例低危乳腺癌患者(≥60岁;cT1-2pN0),放疗方案为10×4 Gy或5×6 Gy,6周后行局部扩大切除。
- 放疗前及放疗后5周(术前)行MRI与FDG PET/CT,以病理反应为参照计算MRI与PET/CT的PPV和NPV。
主要发现
- 66例中病理反应(近)完全缓解15例(23%),部分缓解28例(42%),无缓解23例(35%)。
- MRI(RECIST)的PPV为87.5%,NPV为85%。
- PET/CT的PPV为25%,NPV为92%。
关键数值与推荐
- MRI(RECIST)预测病理完全缓解的PPV为87.5%,NPV为85%。
- PET/CT预测病理完全缓解的PPV为25%,NPV为92%。
- 病理(近)完全缓解15/66例(23%),部分缓解28/66例(42%),无缓解23/66例(35%)。
临床怎么用
- 对于低危乳腺癌术前部分乳腺照射后的疗效评估,可优先采用MRI结合RECIST判断缓解与残留病灶。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to find indicators for early response to radiation therapy in breast cancer. These would be of help in tailoring treatment for individual patients. METHODS AND MATERIALS: We analyzed 66 patients with low-risk breast cancer (≥60 years; cT1-2pN0) treated within the Preoperative Accelerated Partial Breast Irradiation (PAPBI) trial. Patients received radiation therapy (RT; 10 x 4 Gray or 5 x 6 Gray), followed by a wide local excision after 6 weeks. Patients underwent magnetic resonance imaging (MRI) and 18F-fluorodexoyglucose (FDG) positron emission tomography/computed tomography (PET/CT) before RT and 5 weeks after RT, before surgery. We assessed the response to PAPBI using a histopathologic assessment and correlated this with responses on MRI and FDG PET/CT. We calculated the positive predictive values (PPVs) of MRI and PET/CT as the number of true positives (complete response on MRI/normalized at visual evaluation on PET/CT and pathologic complete response) divided by the number of patients with a complete response on MRI/normalized at visual evaluation on PET/CT. Similarly, the negative predictive values (NPVs) of MRI and PET/CT were calculated. RESULTS: The pathologic response was (nearly) complete in 15 (23%) of the 66 patients and partially complete in 28 (42%). The remaining 23 patients (35%) were nonresponders. The PPV of MRI (Response evaluation criteria in solid tumors [RECIST]) was 87.5% and the NPV was 85%. The PPV and NPV of PET/CT were 25% and 92%, respectively. CONCLUSIONS: The most accurate method to predict a response and residual disease after preoperative RT in low-risk breast cancer was MRI, using RECIST.
引用
- Bosma SCJ, van der Leij F, Elkhuizen PHM, et al. Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT). Int J Radiat Oncol Biol Phys. 2021. PMID: 33647369. doi:10.1016/j.ijrobp.2021.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。